Literature DB >> 9713837

Endovascular therapy of brain AVMs prior to radiosurgery.

H Henkes1, H C Nahser, E Berg-Dammer, W Weber, S Lange, D Kühne.   

Abstract

The purposes of this study were to determine the safety and efficacy of embolization of brain AVMs prior to radiosurgery and to evaluate the total obliteration rate achieved. The brain AVMs of 64 patients were subselectively embolized mainly with NBCA, platinum microcoils and/or PVA. The aim of embolization was the reduction of the target volume and/or the elimination of vascular structures bearing an increased risk of hemorrhage. Presenting symptoms were intracranial hemorrhage in 33 patients, a seizure disorder in 21 patients, and headache in 6 patients. Four AVMs had been detected as an incidental finding. The initial AVM volume was in the range of 0.5 to 84 cc (mean 17 cc). Grading of the AVMs according to the Spetzler-Martin scale showed the following distribution: grade I, 3x; II, 13x; III, 11x; IV, 17x; V, 4x; VI, 16x. A total of 300 endovascular procedures including 47 subselective catheterizations without and 253 with embolization were performed. A size reduction of the AVMs between 10% and 95% (mean 63%, median 70%) was achieved. Neurological symptoms due to treatment complications were transient in 12 patients, of minor clinical significance but permanent in 4 patients. Following radiosurgery, one patient died due to recurrent intracerebral hemorrhage. Three patients are doing well but refused final follow-up angiography. A total of 30 patients is currently within the latency interval after radiosurgery. Radiosurgery failed to obliterate the embolized AVMs in 16 patients. Angiography confirmed complete nidus obliteration in 14 patients. The endovascular treatment of brain AVMs prior to radiosurgery proved safe and effective and may be considered in either high grade or incidental AVMs. AVM obliteration after embolization and radiosurgery is less frequently achieved than after stereotactic irradiation of primarily small AVMs.

Entities:  

Mesh:

Year:  1998        PMID: 9713837     DOI: 10.1080/01616412.1998.11740552

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  16 in total

1.  Superior vena cava syndrome caused by embolisation of liquid Onyx.

Authors:  Robbert Crusio; Kishan Ramachandran; Kavan Ramachandran; Yizhak Kupfer; Sidney Tessler
Journal:  BMJ Case Rep       Date:  2011-02-14

2.  Onyx (Ethylene-vinyl Alcohol Copolymer) in Peripheral Applications.

Authors:  Marcelo Guimaraes; Mathew Wooster
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

3.  Brain AVM embolization with Onyx.

Authors:  W J van Rooij; M Sluzewski; G N Beute
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

4.  Intraventricular hemorrhage secondary to intranidal aneurysm rupture-successful management by arteriovenous malformation embolization followed by intraventricular tissue plasminogen activator: case report.

Authors:  Glen A Pollock; Ali Shaibani; Issam Awad; H Hunt Batjer; Bernard R Bendok
Journal:  Neurosurgery       Date:  2011-02       Impact factor: 4.654

5.  Endovascular therapy followed by stereotactic radiosurgery for cerebral arteriovenous malformations.

Authors:  Y Arai; Y Handa; H Ishii; Y Ueda; H Uno; T Nakajima; S Hirose; T Kubota
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

6.  Interdisciplinary clinical management of high grade arteriovenous malformations and ruptured flow-related aneurysms in the posterior fossa.

Authors:  A Mpotsaris; C Loehr; A Harati; F Lohmann; M Puchner; W Weber
Journal:  Interv Neuroradiol       Date:  2010-12-17       Impact factor: 1.610

7.  Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients.

Authors:  C Mounayer; N Hammami; M Piotin; L Spelle; G Benndorf; I Kessler; J Moret
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

8.  Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life.

Authors:  A J Easey; G M F Wallace; J M B Hughes; J E Jackson; W J Taylor; C L Shovlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-06       Impact factor: 10.154

9.  Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients.

Authors:  Vasilios Katsaridis; Chrysanthi Papagiannaki; Enrico Aimar
Journal:  Neuroradiology       Date:  2008-04-12       Impact factor: 2.804

10.  Superselective Intra-Arterial Ethanol Sclerotherapy of Feeding Artery and Nidal Aneurysms in Ruptured Cerebral Arteriovenous Malformations.

Authors:  F Settecase; S W Hetts; A D Nicholson; M R Amans; D L Cooke; C F Dowd; R T Higashida; V V Halbach
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.